Acadia Healthcare (NASDAQ:ACHC) Shares Gap Down – Here’s What Happened

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) gapped down prior to trading on Thursday . The stock had previously closed at $14.33, but opened at $13.85. Acadia Healthcare shares last traded at $15.0450, with a volume of 1,552,705 shares trading hands.

Wall Street Analysts Forecast Growth

ACHC has been the subject of several analyst reports. TD Cowen reaffirmed a “reduce” rating on shares of Acadia Healthcare in a report on Friday, January 16th. Raymond James Financial set a $17.00 target price on Acadia Healthcare in a research report on Wednesday, December 3rd. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a report on Wednesday. Barclays decreased their price objective on Acadia Healthcare from $17.00 to $14.00 and set an “equal weight” rating on the stock in a research note on Thursday, December 4th. Finally, Bank of America downgraded Acadia Healthcare from a “neutral” rating to an “underperform” rating and cut their target price for the stock from $21.50 to $13.00 in a research note on Wednesday, December 3rd. Six analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $18.62.

Acadia Healthcare Stock Up 0.5%

The company has a market cap of $1.41 billion, a PE ratio of 13.02, a P/E/G ratio of 4.31 and a beta of 0.88. The stock has a 50-day moving average of $14.47 and a 200-day moving average of $19.65. The company has a quick ratio of 1.44, a current ratio of 1.44 and a debt-to-equity ratio of 0.73.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share for the quarter, topping analysts’ consensus estimates of $0.71 by $0.01. The business had revenue of $851.57 million for the quarter, compared to analyst estimates of $852.43 million. Acadia Healthcare had a return on equity of 7.66% and a net margin of 3.29%.The company’s quarterly revenue was up 4.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.91 EPS. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. Sell-side analysts predict that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Acadia Healthcare

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Allworth Financial LP raised its position in shares of Acadia Healthcare by 676.4% during the 2nd quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock valued at $31,000 after buying an additional 1,177 shares in the last quarter. EverSource Wealth Advisors LLC increased its stake in Acadia Healthcare by 54.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after acquiring an additional 497 shares during the last quarter. Hantz Financial Services Inc. raised its position in Acadia Healthcare by 501.9% during the third quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock valued at $54,000 after purchasing an additional 1,822 shares in the last quarter. CWM LLC lifted its stake in Acadia Healthcare by 105.1% during the second quarter. CWM LLC now owns 2,633 shares of the company’s stock worth $60,000 after purchasing an additional 1,349 shares during the last quarter. Finally, GAMMA Investing LLC boosted its holdings in shares of Acadia Healthcare by 124.7% in the 4th quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock worth $69,000 after purchasing an additional 2,698 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.